Expert Network for Women in Healthcare and Life Sciences
This network connects women economists and academics working on healthcare and life sciences topics and offers an opportunity to learn about expert witness work.
Bringing New Science to Market
Sean Nicholson of Cornell University will speak at this event about innovation, adoption, and policy challenges in the healthcare industry.
ASHEcon 2023: The Annual Conference of the American Society of Health Economists
Caitlyn Fleming will speak at this annual event about the varied settings in which health economists contribute expertise.
21st Annual International Industrial Organization Conference (IIOC)
Cornerstone Research affiliated experts will be honored and present at this annual conference in Washington, DC.
Life Sciences Capabilities
From initial strategy through deposition and trial, clients have used our findings in hundreds of matters involving the life sciences industry.
Intersection of Intellectual Property and Competition Policy in Recent Cases
The authors discuss high-profile cases in the EU and US that concern IP rights and competition policy.
Why Curve-Fitting Cannot Be Used to Show Causation or Estimate Impact
Iain Cockburn discusses the problems with curve-fitting methodology in economic analysis in this Westlaw article.
Evaluating Innovation Theories of Harm in Merger Review: Economic Frameworks and Difficulties
The authors discuss recent life science cases that deal with innovation theories of harm, and what economic models can be useful in reviewing proposed mergers in this space.
Federal Trade Commission v. 1-800 Contacts
The Second Circuit Court of Appeals overturned an FTC decision regarding trademark enforcement against online competitors.
Cornerstone Research Staff and Experts Submit Comments to Multilateral Pharmaceutical Merger Task Force
Comments emphasize the need for the FTC to consider the varied effects of mergers on innovation.
Alleged Failure to Disclose Drug Safety Issues
Cornerstone Research was retained by a pharmaceutical company facing securities litigation after it withdrew a drug from the market because of safety concerns.
How can we help you?
If you are looking for a publication not on our website, contact us.